DEA Proposes Controlling Norfentanyl as Schedule II Controlled Substance

September 23, 2019

The Drug Enforcement Agency (DEA) is proposing to list norfentanyl used in the illicit manufacture of fentanyl as a Schedule II controlled substance.

The agency found that the substance meets three criteria to be designated an “immediate precursor,” meaning that it can be considered a Schedule II controlled substance.

The DEA is seeking public comment from legitimate industries that use the substance and the potential burden the proposed regulatory controls may have on their activities.

View today's stories